申请人:BEECHAM GROUP PLC
公开号:EP0120426A1
公开(公告)日:1984-10-03
Compounds formula (I):
wherein:
one of R1 and R2 is hydrogen and the other is Ci-6 alkyl-thiocarbonyl, C1-6 alkoxy-thiocarbonyl, C1-6 alkyl-thio- car- bonyloxy, 1-mercapto C2-7alkyl orformyl;
one of R3 and R4 is hydrogen or C1-4 alkyl and the other is C1-4 alkyl, or R3 and R4 together with the carbon atom to which they are attached are C3-6 spiroalkyl;
R5 is hydrogen, C1-3 alkyl or C1-8 acyl; and
n is 1 or 2; the lactam group being trans to the OR. group, having anti-hypertensive activity.
式(I)化合物:
其中
R1 和 R2 中的一个是氢,另一个是 Ci-6 烷基-硫代羰基、C1-6 烷氧基-硫代羰基、C1-6 烷基-硫代碳酰氧基、1-巯基 C2-7 烷基或甲酰基;
R3 和 R4 中的一个是氢或 C1-4 烷基,另一个是 C1-4 烷基,或 R3 和 R4 与它们所连接的碳原子一起是 C3-6 螺烷基;
R5 是氢、C1-3 烷基或 C1-8 丙烯酸基;以及
内酰胺基团与 OR.基团反式连接,具有抗高血压活性。